AHA today urged the Centers for Medicare & Medicaid Services to provide flexibility regarding the agency’s new COVID-19 test documentation requirement for the diagnostic-related group add-on payment.

“This new requirement will put substantial administrative burden on hospitals at a time when they are focusing their efforts and resources on critical patient care,” the association wrote. “Thus, we urge CMS to allow provider documentation to suffice if the test result is unavailable.”

The Coronavirus Aid, Relief, and Economic Security Act provided a 20% add-on to the inpatient prospective payment system DRG rate for patients diagnosed with COVID-19 during the public health emergency. CMS recently added a requirement to have a positive COVID-19 laboratory test documented in the patient’s medical record in order for the claim to be eligible. The new requirement would be applied to admissions on or after Sept. 1, 2020.

“We have heard from our hospital members that acquiring test results from other health care providers, local testing centers and other third party entities can be a burdensome process, sometimes resulting in long delays or unobtainable results,” the letter notes. “In order to receive the add-on payment, hospitals would have to dedicate considerable time and effort to obtain a patient’s third party result to manually add into the medical record, and in some cases would ultimately have to re-test the patient.”

Related News Articles

Headline
The White House Feb. 1 announced it placed tariffs on imported goods from Canada, Mexico and China. The tariffs for Mexico and Canada have since been delayed…
Headline
The AHA Jan. 28 voiced support for bipartisan legislation to reauthorize for five years the Dr. Lorna Breen Health Care Provider Protection Act, which provides…
Chairperson's File
There is so much for health care leaders to navigate when it comes to public policy and government relations. Thankfully, the AHA has an expert team with…
Headline
Sens. Dick Durbin, D-Ill., and Chuck Grassley, R-Iowa, Jan. 23 introduced the Drug-price Transparency for Consumers Act, legislation supported by the AHA that…
Perspective
All eyes this week have been on Washington, D.C., as President Trump was inaugurated and the 119th Congress — with Republicans holding majorities in the House…
Headline
The AHA yesterday released its 2025 Advocacy Agenda that details the association's key priorities for Congress, the Administration, regulatory agencies and…